Association between acetylator genotype and 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in colon and prostate of inbred Fischer 344 and Wistar Kyoto rats

Cancer Letters

Volumn 149, Issue 1-2, 2000, Pages 53-60

  Purewal, Madhu ^a   Fretland, Adrian J ^b   Schut, Herman A J ^c   Hein, David W ^b   Wargovich, Michael J ^a,d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d South Carolina Cancer Center   (United States)

Author keywords

2 Amino 1 methyl 6 phenylimidazo 4,5 b pyridine (PhIP); DNA adducts; Heterocyclic amines; Inbred rats; N Acetyltransferase

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 4 AMINOBENZOIC ACID DERIVATIVE; ACYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; COLON; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; INBRED STRAIN; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; TISSUE LEVEL;

ANIMALS; CARCINOGENS; COLON; COLONIC NEOPLASMS; DNA ADDUCTS; GENETIC PREDISPOSITION TO DISEASE; IMIDAZOLES; MALE; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, INBRED F344; RATS, INBRED WKY; SPECIES SPECIFICITY;

EID: 0033982771     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00346-8     Document Type: Article

References (36)

1. Johansson M.A., Jagerstad M. Occurrence of mutagenic/carcinogenic heterocyclic amines in meat and fish products, including pan residues, prepared under domestic conditions. Carcinogenesis. 15:1994;1511-1518.
2. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;39-52.
3. Hasegawa R., Sano M., Tamano S., Imaida K., Shirai T., Nagao M., Sugimura T., Ito N. Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) carcinogenicity in rats. Carcinogenesis. 14:1993;2553-2557.
4. Imaida K., Hagiwara A., Yada H., Masui T., Hasegawa R., Hirose M., Sugimura T., Ito N., Shirai T. Dose-dependent induction of mammary carcinomas in female Sprague-Dawley rats with 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine. Jpn. J. Cancer Res. 87:1996;1116-1120.
5. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res. 57:1997;195-198.
6. Cummings D.A., Schut H.A. Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat. Carcinogenesis. 15:1994;2623-2628.
7. Takahashi S., Tamano S., Hirose M., Kimoto N., Ikeda Y., Sakakibara M., Tada M., Kadlubar F., Ito N. Immunohistochemical demonstration of carcinogen-DNA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimdazo[4,5-b]pyridine (PhIP): Detection in paraffin-embedded sections and tissue distribution. Cancer Res. 58:1998;4307-4313.
8. Schut H.A., Herzog C.R. Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in male Fischer-344 rats. Cancer Lett. 67:1992;117-124.
9. Kaderlik K.R., Minchin R.F., Mulder G.J., Ilett K.F., Daugaard-Jenson M., Teitel C.H., Kadlubar F.F. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis. 15:1994;1703-1709.
10. Lin D., Kaderlik K.R., Turesky R.J., Miller D.W., Lay J.O.J., Kadlubar F.F. Identification of N-(deoxyguanosin-8-yl)-2-amino-1-mrthyl-6-phenylimidazo[4,5-b]pyridine as the major food adduct formed by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine with DNA. Chem. Res. Toxicol. 5:1992;691-697.
11. Grant D.M., Hughes N.C., Janezic S.A., Goodfellow G.H., Chen H.J., Gaedigk A., Yu V.L., Grewal R. Human acetyltransferase polymorphisms. Mutat. Res. 376:1997;61-70.
12. Minchin R.F., Reeves P.T., Teitel C.H., McManus M.E., Mojarrabi B., Ilett K.F., Kadlubar F.F. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185:1992;839-844.
13. Hein D.W., Rustan T.D., Ferguson R.J., Doll M.A., Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol. 68:1994;129-133.
14. Lang N.P., Butler M.A., Massengill J., Lawson M., Stotts R.C., Hauer-Jensen M., Kadlubar F.F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 3:1994;675-682.
15. Hein D.W. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol. Lett. 1999;in press.
16. Remer H., Grein H., Schenkman J.B., Estabrook R.W. Methods for the elevation of hepatic microsomal mixed function oxidase levels and cytochrome P-450. Methods Enzymol. 10:1967;703-708.
17. Crofts F.G., Strickland P.T., Hayes C.L., Sutter T.R. Metabolism of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis. 18:1997;193-198.
18. Doll M.A., Jiang W., Deitz A.C., Rustan T.D., Hein D.W. Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun. 233:1997;584-591.
19. Trinidad A., Hein D.W., Rustan T.D., Ferguson R.J., Miller L.S., Bucher K.D., Kirlin W.G., Ogolla F., Andrews A.F. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase. Cancer Res. 50:1990;7942-7949.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
21. Randerath E., Agrawal H.P., Weaver J.A., Bordelon C.B., Randerath K. 32P-postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 6:1985;1117-1126.
22. Ito N., Hasegawa R., Imaida K., Tamano S., Hagiwara A., Hirose M., Shirai T. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat. Res. 376:1997;107-114.
23. Hein D.W., Rustan T.D., Bucher K.D., Furman E.J., Martin W.J. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J. Pharmacol. Exp. Ther. 258:1991;232-236.
24. Fretland A.J., Feng Y., Hein D.W. DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. West Pharmacol. Soc. 40:1997;9-12.
25. Hein D.W., Doll M.A., Fretland A.J., Gray K., Deitz A.C., Feng Y., Jiang W., Rustan T.D., Satran S.L., Wilkie T.R. Sr. Rodent models of the human acetylation polymorphism: comparisons of recombinant acetyltransferases. Mutat. Res. 376:1997;101-106.
26. Hein D.W., Rustan T.D., Bucher K.D., Martin W.J., Furman E.J. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab. Dispos. 19:1991;933-937.
27. Doll M.A., Hein D.W. Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats. Pharmacogenetics. 5:1995;247-251.
28. Hein D.W., Doll M.A., Gray K., Rustan T.D., Ferguson R.J. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res. 53:1993;509-514.
29. Hein D.W., Doll M.A., Rustan T.D., Gray K., Feng Y., Ferguson R.J., Grant D.M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis. 14:1993;1633-1638.
30. Hein D.W., Rustan T.D., Bucher K.D., Martin W.J., Furman E.J. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab. Dispos. 19:1991;933-937.
31. Hein D.W., Flammang T.J., Kirlin W.G., Trinidad A., Ogolla F. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase. Carcinogenesis. 8:1987;1767-1774.
32. Chou H.C., Lang N.P., Kadlubar F.F. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res. 55:1995;525-529.
33. Lin D., Meyer D.J., Ketterer B., Lang N.P., Kadlubar F.F. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res. 54:1994;4920-4926.
34. Fretland A.J., Feng Y., Hein D.W. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) DNA adduct formation in homozygous rapid and slow acetylator congenic hamsters. Toxicol. Sci. 42:1998;281.
35. Feng Y., Fretland A.J., Rustan T.D., Jiang W., Becker W.K., Hein D.W. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2′-dimethyl-4- aminobiphenyl. Toxicol. Appl. Pharmacol. 147:1997;56-62.
36. Sesardic D., Edwards R.J., Davies D.S., Thomas P.E., Levin W., Boobis A.R. High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat. Biochem. Pharmacol. 39:1990;489-498.